Title of article
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
Author/Authors
Jean-Claude Tardif، نويسنده , , John J.V. McMurray، نويسنده , , Eric Klug، نويسنده , , Robert Small، نويسنده , , Jennifer Schumi، نويسنده , , Jasmine Choi، نويسنده , , Jim Cooper، نويسنده , , Robert Scott، نويسنده , , Eldrin F Lewis، نويسنده , , Philippe L LʹAllier، نويسنده , , Marc A Pfeffer، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
8
From page
1761
To page
1768
Abstract
Background
Oxidative stress and inflammation are involved in the pathophysiology of atherosclerosis. Our aim was to assess the effects of the antioxidant succinobucol (AGI-1067) on cardiovascular outcomes in patients with recent acute coronary syndromes a
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
592923
Link To Document